HC Wainwright Cuts electroCore (NASDAQ:ECOR) Price Target to $18.00

electroCore (NASDAQ:ECOR) had its price objective trimmed by HC Wainwright from $25.00 to $18.00 in a report released on Monday morning,Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for electroCore’s Q4 2025 earnings at ($0.30) EPS, FY2025 earnings at ($1.62) EPS, Q1 2026 earnings at ($0.50) EPS, Q2 2026 earnings at ($0.57) EPS, Q3 2026 earnings at ($0.33) EPS, Q4 2026 earnings at ($0.26) EPS, FY2026 earnings at ($1.65) EPS, FY2027 earnings at ($0.86) EPS, FY2028 earnings at ($0.23) EPS, FY2029 earnings at $0.30 EPS and FY2030 earnings at $0.90 EPS.

A number of other research analysts have also recently weighed in on ECOR. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a research report on Monday, December 29th. Wall Street Zen raised shares of electroCore from a “sell” rating to a “hold” rating in a research note on Saturday, November 8th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, electroCore presently has a consensus rating of “Hold” and a consensus target price of $22.00.

electroCore Trading Down 8.0%

Shares of electroCore stock opened at $7.25 on Monday. The business’s fifty day moving average price is $5.42 and its 200 day moving average price is $5.48. electroCore has a twelve month low of $4.16 and a twelve month high of $19.49. The stock has a market capitalization of $58 million, a P/E ratio of -4.24 and a beta of 0.34.

electroCore (NASDAQ:ECOR) last released its quarterly earnings data on Wednesday, November 5th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%.The firm had revenue of $8.69 million during the quarter, compared to analysts’ expectations of $7.84 million. As a group, sell-side analysts predict that electroCore will post -1.49 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. FNY Investment Advisers LLC acquired a new stake in electroCore during the 4th quarter valued at $82,000. Two Sigma Investments LP boosted its position in electroCore by 20.8% in the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after buying an additional 4,231 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new stake in shares of electroCore during the first quarter valued at about $153,000. Jaffetilchin Investment Partners LLC grew its stake in shares of electroCore by 26.7% during the second quarter. Jaffetilchin Investment Partners LLC now owns 41,783 shares of the company’s stock valued at $221,000 after acquiring an additional 8,800 shares in the last quarter. Finally, Jane Street Group LLC increased its position in shares of electroCore by 114.4% during the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after acquiring an additional 19,599 shares during the last quarter. 26.74% of the stock is owned by institutional investors and hedge funds.

electroCore News Summary

Here are the key news stories impacting electroCore this week:

• Positive Sentiment: HC Wainwright kept a “Buy” rating and an $18.00 price target on ECOR, and made a small upward tweak to FY2025 (-$1.62 from -$1.63), which provides some medium?term support despite cuts to other years. HC Wainwright note
• Neutral Sentiment: Reported short interest data for January shows “0” shares and a 0.0 days short?interest ratio — this appears to be a data anomaly or indicates no concentrated short positioning; it’s not providing meaningful upward or downward pressure today.
• Neutral Sentiment: There is an article about “Ecora Royalties” (ticker ECOR on other exchanges) in market headlines; that company is unrelated to electroCore (NASDAQ: ECOR) and can be ignored for equity moves in the U.S. listing. Ecora Royalties trading update
• Negative Sentiment: HC Wainwright issued a series of downward revisions across 2026 quarters and later years (Q1–Q4 2026 and FY2026–FY2029), including a large cut to FY2026 EPS (to -$1.65 from a prior $0.32) and much lower near?term quarterly forecasts — this materially weakens near?term profitability expectations and is the likely primary cause of today’s sell?off. HC Wainwright revisions

About electroCore

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.